Inhibition of cell migration by PITENINs: The role of ARF6

Oncogene

Volumn 31, Issue 39, 2012, Pages 4317-4332

  Miao, B ^a   Skidan, I ^b   Yang, J ^c   You, Z ^a   Fu, X ^d   Famulok, M ^d,e   Schaffhausen, B ^a   Torchilin, V ^b   Yuan, J ^f   Degterev, A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d TUFTS UNIVERSITY   (United States)

^e UNIVERSITY OF BONN   (Germany)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

anti angiogenesis; anti metastasis; ARF6 guanine nucleotide exchange factor; ARNO GRP1 membrane translocation; lamellipodia suppression

Indexed keywords

ACTIN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; ANTINEOPLASTIC AGENT; GENERAL RECEPTOR FOR 3 PHOSPHOINOSITIDE; GROWTH FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; NUCLEOTIDE BINDING SITE OPENER; PHOSPHATIDYLINOSITOL 3,4,5 TRIPHOSPHATE ANTAGONIST; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PLECKSTRIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; LAMELLIPODIUM; METASTASIS; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; TUMOR VASCULARIZATION;

ACTINS; ADP-RIBOSYLATION FACTORS; ANGIOGENESIS INHIBITORS; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETON; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLINOSITOL PHOSPHATES; RATS; RATS, SPRAGUE-DAWLEY; SKIN NEOPLASMS;

EID: 84867065356     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.593     Document Type: Article

References (38)

1. Avraamides CJ, Garmy-Susini B, Varner JA. (2008). Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 8: 604-617.
2. Balana ME, Niedergang F, Subtil A, Alcover A, Chavrier P, Dautry-Varsat A. (2005). ARF6 GTPase controls bacterial invasion by actin remodelling. J Cell Sci 118: 2201-2210.
3. Cantley LC. (2002). The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
4. Caumont AS, Vitale N, Gensse M, Galas MC, Casanova JE, Bader MF. (2000). Identification of a plasma membrane-associated guanine nucleotide exchange factor for ARF6 in chromaffin cells. Possible role in the regulated exocytotic pathway. J Biol Chem 275: 15637-15644.
5. Cavenagh MM, Whitney JA, Carroll K, Zhang C, Boman AL, Rosenwald AG et al. (1996). Intracellular distribution of Arf proteins in mammalian cells. Arf6 is uniquely localized to the plasma membrane. J Biol Chem 271: 21767-21774.
6. Chardin P, Paris S, Antonny B, Robineau S, Beraud-Dufour S, Jackson CL et al. (1996). A human exchange factor for ARF contains Sec7-and pleckstrin-homology domains. Nature 384: 481-484.
7. Cox R, Mason-Gamer RJ, Jackson CL, Segev N. (2004). Phylogenetic analysis of Sec7-domain-containing Arf nucleotide exchangers. Mol Biol Cell 15: 1487-1505.
8. Donaldson JG. (2003). Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem 278: 41573-41576.
9. Esteban PF, Yoon HY, Becker J, Dorsey SG, Caprari P, Palko ME et al. (2006). A kinase-deficient TrkC receptor isoform activates Arf6-Rac1 signaling through the scaffold protein tamalin. J Cell Biol 173: 291-299.
10. Frank S, Upender S, Hansen SH, Casanova JE. (1998a). ARNO is a guanine nucleotide exchange factor for ADP-ribosylation factor 6. J Biol Chem 273: 23-27.
11. Frank SR, Hatfield JC, Casanova JE. (1998b). Remodeling of the actin cytoskeleton is coordinately regulated by protein kinase C and the ADP-ribosylation factor nucleotide exchange factor ARNO. Mol Biol Cell 9: 3133-3146.
12. Gillingham AK, Munro S. (2007). The small G proteins of the Arf family and their regulators. Annu Rev Cell Dev Biol 23: 579-611.
13. Hafner M, Schmitz A, Grune I, Srivatsan SG, Paul B, Kolanus W et al. (2006). Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature 444: 941-944.
14. Hashimoto S, Onodera Y, Hashimoto A, Tanaka M, Hamaguchi M, Yamada A et al. (2004). Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci USA 101: 6647-6652.
15. Hornstein I, Alcover A, Katzav S. (2004). Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 16: 1-11.
16. Hu B, Shi B, Jarzynka MJ, Yiin JJ, D'Souza-Schorey C, Cheng SY. (2009). ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway. Cancer Res 69: 794-801.
17. Jackson CL, Casanova JE. (2000). Turning on ARF: the Sec7 family of guanine-nucleotide-exchange factors. Trends Cell Biol 10: 60-67.
18. Kavran JM, Klein DE, Lee A, Falasca M, Isakoff SJ, Skolnik EY et al. (1998). Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains. J Biol Chem 273: 30497-30508.
19. Klarlund JK, Guilherme A, Holik JJ, Virbasius JV, Chawla A, Czech MP. (1997). Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and Sec7 homology domains. Science 275: 1927-1930.
20. Klarlund JK, Rameh LE, Cantley LC, Buxton JM, Holik JJ, Sakelis C et al. (1998). Regulation of GRP1-catalyzed ADP ribosylation factor guanine nucleotide exchange by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 1859-1862.
21. Langille SE, Patki V, Klarlund JK, Buxton JM, Holik JJ, Chawla A et al. (1999). ADP-ribosylation factor 6 as a target of guanine nucleotide exchange factor GRP1. J Biol Chem 274: 27099-27104.
22. Macia E, Luton F, Partisani M, Cherfils J, Chardin P, Franco M. (2004). The GDP-bound form of Arf6 is located at the plasma membrane. J Cell Sci 117: 2389-2398.
23. Macia E, Partisani M, Favard C, Mortier E, Zimmermann P, Carlier MF et al. (2008). The pleckstrin homology domain of the Arf6-specific exchange factor EFA6 localizes to the plasma membrane by interacting with phosphatidylinositol 4,5-bisphosphate and F-actin. J Biol Chem 283: 19836-19844.
24. Miao B, Skidan I, Yang J, Lugovskoy A, Reibarkh M, Long K et al. (2010). Small molecule inhibition of phosphatidylinositol-3,4, 5-triphosphate (PIP3) binding to pleckstrin homology domains. Proc Natl Acad Sci USA 107: 20126-20131.
25. Muralidharan-Chari V, Hoover H, Clancy J, Schweitzer J, SuckowMA, Schroeder V et al. (2009). ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo. Cancer Res 69: 2201-2209.
26. Nie Z, Hirsch DS, Randazzo PA. (2003). Arf and its many interactors. Curr Opin Cell Biol 15: 396-404.
27. Park WS, Heo WD, Whalen JH, O'Rourke NA, Bryan HM, Meyer T et al. (2008). Comprehensive identification of PIP3-regulated PH domains from C. elegans to H. sapiens by model prediction and live imaging. Mol Cell 30: 381-392.
28. Renault L, Guibert B, Cherfils J. (2003). Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor. Nature 426: 525-530.
29. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. (1992). The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70: 401-410.
30. Santy LC, Casanova JE. (2001). Activation of ARF6 by ARNO stimulates epithelial cell migration through downstream activation of both Rac1 and phospholipase D. J Cell Biol 154: 599-610.
31. Simpson KJ, Dugan AS, Mercurio AM. (2004). Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res 64: 8694-8701.
32. Tague SE, Muralidharan V, D'Souza-Schorey C. (2004). ADPribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway. Proc Natl Acad Sci USA 101: 9671-9676.
33. Varnai P, Bondeva T, Tamas P, Toth B, Buday L, Hunyady L et al. (2005). Selective cellular effects of overexpressed pleckstrinhomology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners. J Cell Sci 118: 4879-4888.
34. Venkateswarlu K, Oatey PB, Tavare JM, Cullen PJ. (1998). Insulin-dependent translocation of ARNO to the plasma membrane of adipocytes requires phosphatidylinositol 3-kinase. Curr Biol 8: 463-466.
35. Viaud J, Zeghouf M, Barelli H, Zeeh JC, Padilla A, Guibert B et al. (2007). Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein-protein complexes. Proc Natl Acad Sci USA 104: 10370-10375.
36. Vivanco I, Sawyers CL. (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
37. Wang F, Herzmark P, Weiner OD, Srinivasan S, Servant G, Bourne HR. (2002). Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat Cell Biol 4: 513-518.
38. Yang CZ, Heimberg H, D'Souza-Schorey C, Mueckler MM, Stahl PD. (1998). Subcellular distribution and differential expression of endogenous ADP-ribosylation factor 6 in mammalian cells. J Biol Chem 273: 4006-4011.